GlaxoSmithKline Pharmaceuticals informs about certificate

07 Oct 2021 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfintech Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th September 2021.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2528.00 43.30 (1.74%)
29-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1478.35
Dr. Reddys Lab 6009.45
Cipla 1491.00
Zydus Lifesciences 1046.55
Lupin 1601.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.